Table: Hisamitsu -6-MTH group results
Oct 11 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2016 Aug 31, 2015 Feb 28, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 74.45 82.43 155.00
(-9.7 pct) (+7.0 pct) (-4.2 pct)
Operating 12.88 14.51 28.00
(-11.3 pct) (+40.1 pct) (+1.0 pct)
Recurring 12.55 14.62 29.00
(-14.1 pct) (-6.1 pct) (+3.5 pct)
Net 9.29 9.38 19.40
(-1.0 pct) (-2.1 pct) (+9.1 pct)
EPS 109.47 yen 109.45 yen 228.69 yen
EPS Diluted 109.42 yen 109.45 yen
Ann Div 81.00 yen 81.00 yen
-Q2 div 40.50 yen 40.00 yen
-Q4 div 41.00 yen 40.50 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO